Ganzina F - Search Results

1

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA.

Mandelli F, Petti MC, Ardia A, Di Pietro N, Di Raimondo F, Ganzina F, Falconi E, Geraci E, Ladogana S, Latagliata R, et al. Mandelli F, et al. Among authors: ganzina f. Eur J Cancer. 1991;27(6):750-5. doi: 10.1016/0277-5379(91)90181-c. Eur J Cancer. 1991. PMID: 1829918 Clinical Trial.

2

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.

Ganzina F, Pacciarini MA, Di Pietro N. Ganzina F, et al. Invest New Drugs. 1986;4(1):85-105. doi: 10.1007/BF00172021. Invest New Drugs. 1986. PMID: 3516918 Review.

3

Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia.

Leone G, Pagano L, Marra R, Di Pietro N, Storti S, Sica S, D'Onofrio G, Ganzina F. Leone G, et al. Among authors: ganzina f. Haematologica. 1989 Jan-Feb;74(1):57-61. Haematologica. 1989. PMID: 2498185

4

Phase II trial with oral idarubicin in advanced breast cancer.

Lopez M, Di Lauro L, Papaldo P, Lazzaro B, Ganzina F, Di Pietro N. Lopez M, et al. Among authors: ganzina f. Invest New Drugs. 1986;4(1):39-42. doi: 10.1007/BF00172014. Invest New Drugs. 1986. PMID: 3457780

5

Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia.

Lambertenghi-Deliliers G, Maiolo AT, Annaloro C, Cortelezzi A, Pogliani E, Ganzina F, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: ganzina f. Eur J Cancer Clin Oncol. 1987 Jul;23(7):1041-5. doi: 10.1016/0277-5379(87)90356-7. Eur J Cancer Clin Oncol. 1987. PMID: 3478198

6

Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.

Lopez M, Di Lauro L, Papaldo P, Ganzina F, Di Pietro N, Lazzaro B. Lopez M, et al. Among authors: ganzina f. Cancer Treat Rep. 1986 Jul;70(7):911-2. Cancer Treat Rep. 1986. PMID: 3459575 No abstract available.

7

Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas.

Abate G, Comella P, Di Pietro N, Ganzina F, Pergola M, Silvestro P, Basso A, Salvatore M, Zarrilli D. Abate G, et al. Among authors: ganzina f. Tumori. 1987 Feb 28;73(1):43-7. doi: 10.1177/030089168707300108. Tumori. 1987. PMID: 3469805

8

Clinical toxicity of 4'-epi-doxorubicin (epirubicin).

Ganzina F, Di Pietro N, Magni O. Ganzina F, et al. Tumori. 1985 Jun 30;71(3):233-40. doi: 10.1177/030089168507100304. Tumori. 1985. PMID: 3861022

9

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.

Lopez M, Vici P, Carpano S, Natali M, Ganzina F, Conti EM, Di Lauro L. Lopez M, et al. Among authors: ganzina f. J Cancer Res Clin Oncol. 1991;117(1):61-4. doi: 10.1007/BF01613198. J Cancer Res Clin Oncol. 1991. PMID: 1997473 Clinical Trial.

10

Epirubicin in non-Hodgkin's lymphomas.

Lopez M, Perno CF, Di Lauro L, Papaldo P, Ganzina F, Di Pietro N. Lopez M, et al. Among authors: ganzina f. Am J Clin Oncol. 1985 Apr;8(2):151-3. doi: 10.1097/00000421-198504000-00008. Am J Clin Oncol. 1985. PMID: 3869431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters